ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,186Medicare Part D Prescriptions Filled, Including Refills

Rank: 158 out of 1677

$676K Total Retail Price of All Prescriptions

Rank: 193 out of 1677

481 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 481 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 13,529 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 1,013 981 1 1
AMLODIPINE BESYLATE 913 879 2 2
TAMSULOSIN HCL 567 541 3 34
METFORMIN HCL 496 484 4 7
FLUTICASONE PROPIONATE 464 447 5 29
LOSARTAN POTASSIUM 452 434 6 25
ALENDRONATE SODIUM 411 411 7 43
TRAMADOL HCL-ACETAMINOPHEN 377 357 8 161
OMEPRAZOLE 339 320 9 6
GLIMEPIRIDE 332 316 10 33
ALLOPURINOL 250 250 11 31
BENAZEPRIL HCL 233 217 12 53
PRAVASTATIN SODIUM 230 216 13 10
HYDROCHLOROTHIAZIDE 225 214 14 9
LOVASTATIN 212 205 15 35
LISINOPRIL 207 198 16 3
METOPROLOL SUCCINATE 197 195 17 23
CRESTOR 191 186 18 28
GABAPENTIN 185 174 19 11
ATENOLOL 163 159 20 21
NEXIUM 147 143 21 19
SERTRALINE HCL 134 133 22 26
LOSARTAN-HYDROCHLOROTHIAZIDE 133 118 23 42
METOPROLOL TARTRATE 121 116 24 12
ADVAIR DISKUS 120 120 25 54
MECLIZINE HCL 119 119 26 110
RANITIDINE HCL 118 117 27 18
TRIAMCINOLONE ACETONIDE 110 100 28 134
NIFEDIPINE ER 108 100 29 98
CARVEDILOL 108 103 29 20
FUROSEMIDE 105 104 31 8
AMLODIPINE BESYLATE-BENAZEPRIL 98 87 32 59
ZOLPIDEM TARTRATE 97 95 33 15
JANUVIA 96 79 34 70
COMBIVENT 95 90 35 105
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 86 36 17
PREDNISONE 92 85 36 40
CELEBREX 85 85 38 102
PROAIR HFA 85 70 38 50
FINASTERIDE 84 84 40 130
DIOVAN 83 81 41 45
PATANOL 80 78 42 355
TRAMADOL HCL 80 68 42 16
HYDROXYZINE HCL 76 74 R 44 148
MELOXICAM 75 72 45 27
NAMENDA 74 74 46 39
LACTULOSE 74 74 46 183
LIDODERM 70 70 48 160
TRIAMTERENE-HCTZ 69 68 49 61
GLIPIZIDE XL 68 68 50 123
DONEPEZIL HCL 63 62 51 30
COLCRYS 61 61 52 141
CLOBETASOL PROPIONATE 57 57 53 259
MIRTAZAPINE 57 57 53 62
GLIPIZIDE 55 42 55 56
CLONIDINE HCL 55 55 55 36
DIOVAN HCT 54 54 57 66
FLUOXETINE HCL 54 54 57 49
HYDROCODONE-ACETAMINOPHEN 53 40 S3 59 4
TRICOR 53 41 59 100
NASONEX 53 44 59 253
LEVOTHYROXINE SODIUM 51 50 62 5
CLOPIDOGREL 50 48 63 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.